EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:EWL - US28176E1082 - Common Stock
73.94 EUR
+0.73 (+1%)
Taking everything into account, EWL scores 7 out of 10 in our fundamental rating. EWL was compared to 62 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, EWL is valued expensive at the moment. This makes EWL very considerable for quality investing!
1. Profitability
1.1 Basic Checks
EWL had positive earnings in the past year.
EWL had a positive operating cash flow in the past year.
In the past 5 years EWL has always been profitable.
In the past 5 years EWL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.31%, EWL belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
EWL's Return On Equity of 13.40% is fine compared to the rest of the industry. EWL outperforms 77.42% of its industry peers.
With a decent Return On Invested Capital value of 9.83%, EWL is doing good in the industry, outperforming 79.03% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EWL is above the industry average of 9.74%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 9.83% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
EWL has a better Profit Margin (23.25%) than 91.94% of its industry peers.
EWL's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 27.73%, EWL belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
In the last couple of years the Operating Margin of EWL has remained more or less at the same level.
With an excellent Gross Margin value of 78.19%, EWL belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
EWL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
Compared to 1 year ago, EWL has less shares outstanding
EWL has less shares outstanding than it did 5 years ago.
EWL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 12.64 indicates that EWL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.64, EWL belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
The Debt to FCF ratio of EWL is 0.75, which is an excellent value as it means it would take EWL, only 0.75 years of fcf income to pay off all of its debts.
EWL's Debt to FCF ratio of 0.75 is amongst the best of the industry. EWL outperforms 91.94% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
The Debt to Equity ratio of EWL (0.06) is better than 85.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.64 |
ROIC/WACC1.13
WACC8.67%
2.3 Liquidity
EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.00, EWL belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
A Quick Ratio of 3.29 indicates that EWL has no problem at all paying its short term obligations.
EWL's Quick ratio of 3.29 is amongst the best of the industry. EWL outperforms 90.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
The earnings per share for EWL have decreased by -3.75% in the last year.
The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
Looking at the last year, EWL shows a small growth in Revenue. The Revenue has grown by 4.67% in the last year.
EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.58% yearly.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
The Earnings Per Share is expected to grow by 9.50% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.55% on average over the next years. This is quite good.
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.5%
Revenue Next Year4.63%
Revenue Next 2Y7.13%
Revenue Next 3Y8.01%
Revenue Next 5Y8.55%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 33.76, which means the current valuation is very expensive for EWL.
The rest of the industry has a similar Price/Earnings ratio as EWL.
When comparing the Price/Earnings ratio of EWL to the average of the S&P500 Index (26.77), we can say EWL is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 29.44, the valuation of EWL can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as EWL.
EWL's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.76 | ||
| Fwd PE | 29.44 |
4.2 Price Multiples
EWL's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 63.09 | ||
| EV/EBITDA | 25.75 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)22.32
PEG (5Y)4.73
EPS Next 2Y6.17%
EPS Next 3Y7.9%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:EWL (12/29/2025, 7:00:00 PM)
73.94
+0.73 (+1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.97%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap42.91B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.05
Price Target81.68 (10.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)0.46%
PT rev (3m)7.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.27%
EPS NY rev (1m)1.08%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.76 | ||
| Fwd PE | 29.44 | ||
| P/S | 8.57 | ||
| P/FCF | 63.09 | ||
| P/OCF | 49.61 | ||
| P/B | 4.94 | ||
| P/tB | 6.91 | ||
| EV/EBITDA | 25.75 |
EPS(TTM)2.19
EY2.96%
EPS(NY)2.51
Fwd EY3.4%
FCF(TTM)1.17
FCFY1.59%
OCF(TTM)1.49
OCFY2.02%
SpS8.62
BVpS14.96
TBVpS10.71
PEG (NY)22.32
PEG (5Y)4.73
Graham Number27.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 9.83% | ||
| ROICexc | 14.65% | ||
| ROICexgc | 23.24% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.64 |
F-Score6
WACC8.67%
ROIC/WACC1.13
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.13%
Revenue Next 3Y8.01%
Revenue Next 5Y8.55%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13%
EBIT Next 3Y12.27%
EBIT Next 5Y12.76%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.
Can you provide the valuation status for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.
What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 33.76 and the Price/Book (PB) ratio is 4.94.
How financially healthy is EDWARDS LIFESCIENCES CORP?
The financial health rating of EDWARDS LIFESCIENCES CORP (EWL.DE) is 10 / 10.